Potassium voltage-gated channels have been extensively investigated as possible therapeutic targets for CHD (45) and other closely related genes, KCNA5 (46) and KCNQ1 (47), have been previously linked to heart disease. The gene discussed is KCNQ1; the disease is coronary artery disorder.